US EditionPublished • loading... • Updated
Ascendis Pharma A/S (NASDAQ:ASND) Trading 8.1% Higher Following Analyst Upgrade
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Ascendis Pharma A/S (NASDAQ:ASND) Trading 8.1% Higher Following Analyst Upgrade
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) shares shot up 8.1% during mid-day trading on Thursday after Stifel Nicolaus raised their price target on the stock from $254.00 to $256.00. Stifel Nicolaus currently has a buy rating on the stock. Ascendis Pharma A/S traded as high as $217.44 and last traded at $217.5550. 923,916 […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
